GENinCode annual loss widens; focuses on US, EU, and NHS in UK
GENinCode on Tuesday reported a larger annual loss as cost of sales and administrative expenses ballooned.
The biotechnology company focused on prevention of cardiovascular disease...
Tue, 06/06/2023 - 14:30